Llorens Pharmaceuticals International Division, Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Sep 26, 2025
  • No warning letters matched by name
Inspections 8 0 OAI
Recalls 1 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Llorens Pharmaceuticals International Division, Inc. has 1 FDA recall, 8 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Llorens Pharmaceuticals International Division, Inc." is on file.

What these totals cover: FDA records filed under the name "Llorens Pharmaceuticals International Division, Inc." and its spelling variant "Llorens Pharmaceuticals International Division".

Latest recall
H-0809-2026 · Class II · May 7, 2026
Latest inspection
Sep 26, 2025 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls1Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections8Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Llorens Pharmaceuticals International Division, Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Llorens Pharmaceuticals International Division, Inc.: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 2 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600010
202520000
202400000
202300000
202200000
202100000
202010000
201910000
201800000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Llorens Pharmaceuticals International Division, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Llorens Pharmaceuticals International Division, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

1 recall record on May 7, 2026.

NumberClassProductDate
H-0809-2026Class IIVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement, Net Wt. 8 FL Oz (237mL) Amber PET…May 7, 2026

Recent FDA inspections

8 inspections from Sep 30, 2010 to Sep 26, 2025.

DateSiteProductClassificationFEI
Sep 26, 2025Miami, FLFood/CosmeticsVoluntary Action Indicated (VAI)3008468946
May 15, 2025Miami, FLDrugsVoluntary Action Indicated (VAI)3008468946
Mar 11, 2020Miami, FLDrugsVoluntary Action Indicated (VAI)3008468946
Aug 29, 2019Miami, FLFood/CosmeticsVoluntary Action Indicated (VAI)3008468946
Jul 12, 2016Miami, FLFood/CosmeticsVoluntary Action Indicated (VAI)3008468946
May 22, 2012Miami, FLFood/CosmeticsNo Action Indicated (NAI)3008468946
Aug 1, 2011Miami, FLDrugsVoluntary Action Indicated (VAI)3008468946
Sep 30, 2010Miami, FLDrugsVoluntary Action Indicated (VAI)3008468946
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3008468946Miami, FL8Sep 26, 2025

Llorens Pharmaceuticals International Division, Inc. and the FDA: common questions

Has Llorens Pharmaceuticals International Division, Inc. received an FDA warning letter?

No FDA warning letter addressed to the name "Llorens Pharmaceuticals International Division, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Llorens Pharmaceuticals International Division, Inc. received an FDA Form 483?

FDA has not published a Form 483 for "Llorens Pharmaceuticals International Division, Inc." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Llorens Pharmaceuticals International Division, Inc.?

The most recent FDA inspection on file ended Sep 26, 2025 at Miami, FL and was classified VAI. FDA has 8 inspections of Llorens Pharmaceuticals International Division, Inc. on file.

Has Llorens Pharmaceuticals International Division, Inc. had an FDA recall?

Yes. Llorens Pharmaceuticals International Division, Inc. has 1 FDA recall on record. The most recent started May 7, 2026.

Need more than this page shows? Ask about Llorens Pharmaceuticals International Division, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.